Functionally, paracrine HGF from PSCs can activate the c-Met/PI3K/Akt pathway in cancer cells, leading to inhibition of cancer cell apoptosis and induction of chemoresistance to gemcitabine [142]. The gene discussed is HGF; the disease is cancer.